TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05492500

A Study of Ponsegromab in People With Heart Failure

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Following a prespecified interim analysis, and in consultation with the independent Data Monitoring Committee, the Sponsor terminated the study”

The sponsor’s own words in the registry.

Life of this trial

202220232024202520262027Registered2022-07-25Started2022-09-26Stopped2025-03-05Results posted2026-03-18

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Pfizer
Sponsor type
Industry
Conditions
Heart Failure
Interventions
Main cohort (Cohort A): Ponsegromab low dose; Main cohort (Cohort A): Ponsegromab medium dose; Main cohort (Cohort A): ponsegromab high dose; Main cohort (Cohort A): Matched placebo; Open-label, PK Cohort (Cohort B): ponsegromab low dose; Open-label, PK Cohort (Cohort B): ponsegromab medium dose
Participants
455
Sites
122
Countries
Australia, Canada, China, Czechia, Germany, Hungary, Japan, Poland, Spain, United Kingdom, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.